Not yet recruiting
Allogenic stem cell transplantation
Not yet recruitingStudy of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia
InvestigationalNo placebo
Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia
InvestigationalNo placebo
- Disease:Allogenic stem cell transplantation
- Substances:DorocubicelAllogeneic umbilical cord-derived CD34- cells, non-expanded
Countries:
The Netherlands
The Netherlands- Participants:18–64 years
- Substances:Dorocubicel